Janus Henderson Group’s BELLUS Health Inc. BLU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-994,579
Closed -$7.17M 2724
2023
Q1
$7.17M Sell
994,579
-9,282
-0.9% -$72K ﹤0.01% 784
2022
Q4
$8.24M Sell
1,003,861
-559,985
-36% -$5.22M 0.01% 761
2022
Q3
$16.5M Buy
1,563,846
+517,740
+49% +$5.5M 0.01% 717
2022
Q2
$9.65M Sell
1,046,106
-602,067
-37% -$4.92M 0.01% 698
2022
Q1
$11.3M Buy
1,648,173
+368,157
+29% +$2.37M 0.01% 865
2021
Q4
$10.3M Sell
1,280,016
-225,246
-15% -$1.49M ﹤0.01% 915
2021
Q3
$9.18M Sell
1,505,262
-438,127
-23% -$1.66M ﹤0.01% 925
2021
Q2
$6.03M Sell
1,943,389
-124,800
-6% -$477K ﹤0.01% 1023
2021
Q1
$7.95M Buy
2,068,189
+211,452
+11% +$802K ﹤0.01% 933
2020
Q4
$5.63M Buy
+1,856,737
New +$5.03M ﹤0.01% 942
2020
Q3
Sell
-232,730
Closed -$2.4M 1379
2020
Q2
$2.4M Buy
232,730
+93,937
+68% +$952K ﹤0.01% 1007
2020
Q1
$1.39M Buy
138,793
+104,703
+307% +$933K ﹤0.01% 1053
2019
Q4
$259K Buy
+34,090
New +$233K ﹤0.01% 1367

Other funds holding BLU

Janus Henderson Group's BLU Position: Q2 2023 in Review

Janus Henderson Group sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 994,579 shares — an estimated $7.17M sold.

Janus Henderson Group first reported a position in BLU in Q4 2019 and held it in 13 quarters. The position peaked at $16.5M in Q3 2022. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

  • Janus Henderson Group reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
  • Janus Henderson Group sold 994,579 BELLUS Health Inc. shares in Q2 2023, an estimated $7.17M.
  • Janus Henderson Group first reported a position in BELLUS Health Inc. in Q4 2019 and held it in 13 quarters.
  • Janus Henderson Group's BELLUS Health Inc. position peaked at $16.5M in Q3 2022.
  • 11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on Janus Henderson Group's 13F filing for Q2 2023, filed 14 Aug 2023.